جاردينس، دواء لإدارة مرض السكري من النوع الثاني، ٢٥ ملغ أقراص

Jardiance 25mg (Empagliflozin) is an oral medication belonging to the class of SGLT2 inhibitors (sodium-glucose co-transporter 2 inhibitors). It is primarily used to manage type 2 diabetes mellitus by helping the kidneys remove excess glucose from the bloodstream through urine. Additionally, it is prescribed to reduce the risk of cardiovascular death in adults with type 2 diabetes and heart disease and to manage heart failure by reducing fluid retention.

Possible Side Effects

Common: Increased urination, urinary tract infections, thirst

Serious: Dehydration, ketoacidosis, low blood pressure, genital infections